FeaturedNeuroscience·June 27, 2022·5 min readMolecular Mechanisms Behind Learning and Memory IdentifiedFindings reveal the molecular mechanism for acetylcholine in learning and memory.Read More
FeaturedNeurologyNeuroscience·March 27, 2021·4 min readCommon Alzheimer’s Treatment Linked to Slower Cognitive DeclineCholinesterase inhibitors such as galantamine, donepezil, and rivastigmine, appear to generate persistent cognitive benefits, and increased longevity for up to five years in Alzheimer's patients.Read More
FeaturedNeuroscienceOpen Neuroscience Articles·August 20, 2019·4 min readAlzheimer’s drug reverses brain damage from adolescent alcohol exposureDonepezil, a drug routinely administered to slow cognitive decline in Alzheimer's disease, shows promise in treating damage caused to the brain by adolescent alcohol exposure. The drug reverses neuroinflammation and neuron damage in rats exposed to alcohol during adolescence.Read More
FeaturedNeurology·February 15, 2018·5 min readAlzheimer’s Drug Repairs Brain Damage After Alcohol Binges: Rat StudyResearchers report a drug used to slow cognitive decline in Alzheimer's disease may help to reverse memory and learning problems in teens who binge drink.Read More
FeaturedOpen Neuroscience ArticlesPsychology·February 18, 2016·5 min readAlzheimer’s Drug Could Help Smokers QuitAccording to a new study, acetylcholinesterase inhibitors commonly used to help treat Alzheimer's disease appear to help smokers reduce cigarette consumption.Read More
FeaturedNeurologyOpen Neuroscience Articles·September 21, 2015·5 min readAlzheimer’s Drug Could Be Used to Treat Bone LossA new study reports a drug commonly used to treat Alzheimer's disease appears to effectively reduce bone loss and prevent fractures.Read More
